This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Akiko Kurimoto: Innovator in Pharmaceutical Chemistry
Introduction
Akiko Kurimoto is a prominent inventor based in Chuo-ku, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic potential.
Latest Patents
Kurimoto holds two patents, both focusing on cycloalkane-1,3-diamine derivatives. These inventions provide compounds or pharmaceutically acceptable salts that exhibit inhibitory actions on the interaction between menin and MLL proteins. The compounds are represented by a specific formula, which includes various defined elements crucial for their functionality.
Career Highlights
She is currently employed at Daiichi Sankyo Company, Limited, where she continues to advance her research and development efforts. Her work is instrumental in the creation of innovative pharmaceutical solutions.
Collaborations
Kurimoto collaborates with notable colleagues, including Kenji Yoshikawa and Noriyasu Haginoya, contributing to a dynamic research environment that fosters innovation.
Conclusion
Akiko Kurimoto's work exemplifies the impact of innovative thinking in pharmaceutical chemistry. Her patents reflect her commitment to advancing medical science and improving therapeutic options.